J Clin Rheumatol 2021 Apr 27. Epub 2021 Apr 27.
From the Lupus and Vasculitis Clinic, Division of Rheumatology, McGill University Health Centre, Montreal, Quebec Division of Rheumatology, Vancouver General Hospital, Vancouver, British Columbia Division of Rheumatology, Sunnybrook Health Sciences Centre Vasculitis Clinic, Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Background/objective: High-dose glucocorticoids (GCs) are required in the initial treatment of systemic vasculitis. However, slow or delayed tapering can lead to unnecessary GC exposure and toxicity. In this quality improvement initiative, we aimed to increase appropriate GC tapering among newly referred patients awaiting specialty consultation at a tertiary vasculitis clinic. Read More